Follow Centrus Energy to never miss an important update.
Centrus has granted special stock awards to its top leadership that are tied strictly to the company's progress in enriching uranium. CEO Amir Vexler was granted 5 million dollars in these units, which only vest if the company successfully achieves enrichment from its first cascade, a series of linked machines used to process nuclear fuel. Other executives, including CFO Todd Tinelli and John Donelson, received 2 million dollars each in awards that vest in stages as the Piketon, Ohio facility reaches these technical milestones.
This move aligns management's pay with the company's most critical goal: proving it can produce high-assay nuclear fuel at a commercial scale. Centrus is currently the only American company licensed to produce this specific fuel for next-generation reactors, but its future value depends entirely on moving from demonstration to full-scale production. By making these awards all-or-nothing based on technical success and cost control, the board is signaling that hitting these operational targets is the only priority that matters for the business right now.
Source: 8-K filing
Centrus has signed a formal contract to provide uranium enrichment services to X-energy, a developer of small modular reactors. The deal covers both standard low-enriched uranium and high-assay low-enriched uranium (HALEU), which is a more concentrated fuel required by next-generation reactor designs.
This agreement is a practical step in turning the company's massive backlog of potential orders into actual business. It includes prepayments from X-energy, providing Centrus with upfront cash to help fund the expansion of its enrichment facilities in Ohio. For a company pivoting from being a middleman for Russian fuel to a domestic producer, securing long-term commitments from advanced reactor developers is essential for proving there is a reliable market for its new production.
Source: PRNewsWire
Roth Capital raised its price target for the stock from $171 to $188. This adjustment follows a quarter where the company beat expectations for both profit and revenue while announcing a major new supply agreement. While the new target is higher, it remains well below the average analyst target of $238, suggesting a more cautious view of how quickly the company can scale its domestic production.
Source: Roth Capital
Centrus delivered a strong second quarter, with revenue of about $176 million coming in well ahead of the $150 million analysts expected. The company earned $0.77 per share, also beating estimates. Beyond the immediate numbers, the company grew its backlog of future contracts to $3 billion, providing a clearer look at long-term demand for its nuclear fuel services.
The company is making progress on its shift toward domestic production, which is critical as the U.S. looks to replace Russian uranium imports. It signed a $900 million contract with the Department of Energy for high-assay fuel enrichment and expects to complete its first new centrifuge by the end of the year. While net income was lower than last year due to the timing of certain deliveries, the underlying growth in the order book suggests the business is successfully positioning itself as a vital piece of the domestic energy supply chain.
See the full quarter, and how our tracked metrics did
Source: 8-K filing
H.C. Wainwright set a price target of $300, which is significantly higher than where the stock currently trades. The firm's view likely centers on the company's position as the only domestic source for the high-assay fuel needed for advanced reactors. This kind of target suggests a belief that the company's regulatory monopoly will lead to substantial long-term value as the U.S. nuclear industry expands.
Source: H.C. Wainwright
The company has a habit of beating analyst targets, often by a wide margin, which suggests management is conservative about what they promise.
| Expectation | |
|---|---|
| EPS | $0.00 |
| Revenue | $68M |
Follow Centrus Energy to get the latest and most important updates.
Follow LEU